| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |